Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DV59ZT
|
|||
| Drug Name |
PR-619
|
|||
| Synonyms |
2645-32-1; 3,5-dithiocyanatopyridine-2,6-diamine; PR 619; (2,6-diamino-5-thiocyanatopyridin-3-yl) thiocyanate; 2,6-Diamino-3,5-dithiocyanopyridine; Thiocyanic acid, 2,6-diamino-3,5-pyridinediyl ester; Thiocyanic acid, C,C'-(2,6-diamino-3,5-pyridinediyl) ester; Maybridge3_003257; CHEMBL4303622; SCHEMBL13024499; AOB1115; DTXSID00384716; EX-A179; BDBM442822; HMS1440E01; HMS3653C09; HMS3874D13; BCP07903; MFCD00830384; s7130; ZINC95725713; AKOS024464520; CCG-266746; CS-1513; QC-8206; 2,6-Diamino-3,5-bisthiocyanatopyridine; IDI1_014644; NCGC00371134-01; AK161038; AS-16618; DA-27532; HY-13814; 3,5-Bis-thiocyanato-pyridine-2,6-diamine; AB0004100; PR-619, >=95% (HPLC); FT-0707844; SW208365-2; EC-000.2543; 2,6-Diamino-3,5-dithiocyanato-pyridin, 98%; 2,6-Diaminopyridine-3,5-diyl bis(thiocyanate); A13190; W-5126; (2,6-diamino-5-thiocyanato-3-pyridyl) thiocyanate; 2,6-Diamino-3,5-bis(thiocyanato)pyridine, PR-619; {[2,6-DIAMINO-5-(CYANOSULFANYL)PYRIDIN-3-YL]SULFANYL}FORMONITRILE
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Esophageal squamous cell carcinoma [ICD-11: 2E60.1; ICD-10: D00.1; ICD-9: 150] | Preclinical | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C7H5N5S2
|
|||
| Canonical SMILES |
C1=C(C(=NC(=C1SC#N)N)N)SC#N
|
|||
| InChI |
1S/C7H5N5S2/c8-2-13-4-1-5(14-3-9)7(11)12-6(4)10/h1H,(H4,10,11,12)
|
|||
| InChIKey |
ZXOBLNBVNROVLC-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 2645-32-1
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Emerging therapies targeting the ubiquitin proteasome system in cancer. J Clin Invest. 2014 Jan;124(1):6-12. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.